<p>(A) CD4∶CD8 ratio in ART-suppressed Individuals at three timepoints (pre-ART, first timepoint on ART and second timepoint on ART). Subjects remained on antiretroviral therapy with suppressed viral load between “first” and “second” timepoint on ART. (B) Naïve subpopulations defined as CD27+CD28hiCCR7+CD45RA+. Proportion and absolute number/ml are depicted for the first and second timepoint. (C) CD4∶CD8 ratio in those suppressed on ART is shown in relationship to proportion of CD8+CD28− cells and also in relationship to the proportion of CMV-specific CD8+ T cells.</p
<p>Figure 4A: Graph displaying CD161++CD8+ T cell frequency (median and interquartile range) from 14...
* the values for patients who started treatment with absolute CD4 between 500 and 650/μl and >650/μl...
<div><p>Among both A) CD4+ and B) CD8+ T cell populations, initiation of raltegravir plus emtricitab...
BACKGROUND: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
BACKGROUND: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
Background: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
<p>For three subjects, CD8+ T cell counts were not available at the pre-ART timepoint. Thus, CD8+ T ...
<p>Data are shown for all study participants (a and c) or patients achieving CD4+ cell counts ≥500/m...
<p>CD4+ and CD8+ T cell counts were enumerated among different patient groups. Non-controllers are H...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to ART vary co...
There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to ...
<p>Figure 4A: Graph displaying CD161++CD8+ T cell frequency (median and interquartile range) from 14...
* the values for patients who started treatment with absolute CD4 between 500 and 650/μl and >650/μl...
<div><p>Among both A) CD4+ and B) CD8+ T cell populations, initiation of raltegravir plus emtricitab...
BACKGROUND: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
Model trajectories of CD4 and CD8 cell counts after starting combination antiretroviral therapy (ART...
BACKGROUND: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
Background: An increasing number of HIV-positive individuals now start antiretroviral therapy (ART) ...
<p>For three subjects, CD8+ T cell counts were not available at the pre-ART timepoint. Thus, CD8+ T ...
<p>Data are shown for all study participants (a and c) or patients achieving CD4+ cell counts ≥500/m...
<p>CD4+ and CD8+ T cell counts were enumerated among different patient groups. Non-controllers are H...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
Objective: Model trajectories of CD4+ and CD8+ cell counts after starting combination antiretroviral...
<p>A) median CD4+ cell count (cells/mm<sup>3</sup>) over time on ART; and, B) percentage of patients...
Although effective antiretroviral therapy(ART) increases CD4+ T-cell count, responses to ART vary co...
There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to ...
<p>Figure 4A: Graph displaying CD161++CD8+ T cell frequency (median and interquartile range) from 14...
* the values for patients who started treatment with absolute CD4 between 500 and 650/μl and >650/μl...
<div><p>Among both A) CD4+ and B) CD8+ T cell populations, initiation of raltegravir plus emtricitab...